- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Veterinary Medicine International
Volume 2014 (2014), Article ID 986806, 6 pages
Comparative Pharmacokinetics of Levofloxacin in Healthy and Renal Damaged Muscovy Ducks following Intravenous and Oral Administration
1Department of Pharmacology, Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh, Qaliobiya 13736, Egypt
2Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
Received 14 November 2013; Accepted 14 December 2013; Published 4 February 2014
Academic Editor: Remo Lobetti
Copyright © 2014 Mohamed Aboubakr and Ahmed Soliman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. K. Bhar, S. Khargharia, A. K. Chakraborty, and T. K. Mandal, “Disposition kinetics of sparfloxacin in healthy, hepatopathic, and nephropathic conditions in chicken after single intravenous administration,” Indian Journal of Pharmacology, vol. 41, no. 3, pp. 106–109, 2009.
- R. Davis and H. M. Bryson, “Levofloxacin: a review of its antibacterial activity, pharmacokinetics and therapeutic efficacy,” Drugs, vol. 47, no. 4, pp. 677–700, 1994.
- G. M. Eliopoulos, C. B. Wennersten, and R. C. Moellering Jr., “Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria,” Diagnostic Microbiology and Infectious Disease, vol. 25, no. 1, pp. 35–41, 1996.
- K. P. Fu, S. C. Lafredo, B. Foleno et al., “In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin,” Antimicrobial Agents and Chemotherapy, vol. 36, no. 4, pp. 860–866, 1992.
- H. D. Langtry and H. M. Lamb, “Levofloxacin: its use in infections of the respiratory tract, skin, soft tissues and urinary tract,” Drugs, vol. 56, no. 3, pp. 487–515, 1998.
- M. Hurst, H. M. Lamb, L. J. Scott, and D. P. Figgitt, “Levofloxacin: an updated review of its use in the treatment of bacterial infections,” Drugs, vol. 62, no. 14, pp. 2127–2167, 2002.
- C. J. Destache, C. B. Pakiz, C. Larsen, H. Owens, and A. K. Dash, “Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model,” Journal of Antimicrobial Chemotherapy, vol. 47, no. 5, pp. 611–615, 2001.
- G. A. Albarellos, L. A. Ambros, and M. F. Landoni, “Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats,” Journal of Veterinary Pharmacology and Therapeutics, vol. 28, no. 4, pp. 363–369, 2005.
- V. K. Dumka and A. K. Srivastava, “Disposition kinetics, urinary excretion and dosage regimen of levofloxacin formulation following single intravenous administration in crossbred calves,” Veterinary Research Communications, vol. 31, no. 7, pp. 873–879, 2007.
- A. Goudah, K. Abo El-Sooud, J.-H. Shim, H.-C. Shin, and A. M. Abd El-Aty, “Characterization of the pharmacokinetic disposition of levofloxacin in stallions after intravenous and intramuscular administration,” Journal of Veterinary Pharmacology and Therapeutics, vol. 31, no. 5, pp. 399–405, 2008.
- A. Goudah, “Pharmacokinetics of levofloxacin in male camels (Camelus dromedarius),” Journal of Veterinary Pharmacology and Therapeutics, vol. 32, no. 3, pp. 296–299, 2009.
- A. Goudah and K. Abo-El-Sooud, “Pharmacokinetics, urinary excretion and milk penetration of levofloxacin in lactating goats,” Journal of Veterinary Pharmacology and Therapeutics, vol. 32, no. 1, pp. 101–104, 2009.
- M. Aboubakr, “Pharmacokinetics of levofloxacin in Japanese quails (Coturnix japonica) following intravenous and oral administration,” British Poultry Science, vol. 53, no. 6, pp. 784–789, 2012.
- J. V. Bennett, J. L. Brodie, E. J. Benner, and W. M. Kirby, “Simplified, accurate method for antibiotic assay of clinical specimens,” Applied Microbiology, vol. 14, no. 2, pp. 170–177, 1966.
- J. D. Baggot, “Some aspects of clinical pharmacokinetics in veterinary medicine,” Journal of Veterinary Pharmacology and Therapeutics, vol. 1, no. 1, pp. 5–18, 1978.
- K. Yamaoka, T. Nakagawa, and T. Uno, “Statistical moments in pharmacokinetics,” Journal of Pharmacokinetics and Biopharmaceutics, vol. 6, no. 6, pp. 547–558, 1978.
- M. Gibaldi and D. Perrier, “Non compartmental analysis based on statistical moment theory,” in Pharmacokinetics, pp. 409–424, Marcel Dekker, New York, NY, USA, 2nd edition, 1982.
- G. W. Snedecor and W. G. Cochran, Statistical Methods, Iowa State University Press, Ames, Iowa, USA, 6th edition, 1976.
- A. Goudah and S. Hasabelnaby, “The disposition of marbofloxacin after single dose intravenous, intramuscular and oral administration to Muscovy ducks,” Journal of Veterinary Pharmacology and Therapeutics, vol. 34, no. 2, pp. 197–201, 2011.
- M. A. Tohamy, “Comparative pharmacokinetics of orbifloxacin in healthy and Pasteurella multocida infected ducks,” British Poultry Science, vol. 52, no. 5, pp. 639–644, 2011.
- L. G. Yuan, R. Wang, L. H. Sun et al., “Pharmacokinetics of marbofloxacin in Muscovy ducks (Cairina moschata),” Journal of Veterinary Pharmacology and Therapeutics, vol. 34, no. 1, pp. 82–85, 2011.
- A. Goudah and S. M. Mouneir, “Disposition kinetics and tissue residues of danofloxacin in Muscovy ducks,” British Poultry Science, vol. 50, no. 5, pp. 613–619, 2009.
- A. Goudah and S. Hasabelnaby, “Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration,” Research in Veterinary Science, vol. 88, no. 3, pp. 507–511, 2010.
- C. M. Blatteis, J. R. S. Hales, A. A. Fawcett, and T. A. Mashburn Jr., “Fever and regional blood flows in wethers and parturient ewes,” Journal of Applied Physiology, vol. 65, no. 1, pp. 165–172, 1988.
- J. P. Fillastre, A. Leroy, B. Moulin, M. Dhib, F. Borsa-Lebas, and G. Humbert, “Pharmacokinetics of quinolones in renal insufficiency,” Journal of Antimicrobial Chemotherapy, vol. 26, supplement B, pp. 51–60, 1990.
- H. P. Lefebvre, M. Schneider, V. Dupouy et al., “Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog,” Journal of Veterinary Pharmacology and Therapeutics, vol. 21, no. 6, pp. 453–461, 1998.
- A. Goudah, “Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens,” British Poultry Science, vol. 50, no. 2, pp. 251–258, 2009.
- S. Pant, G. S. Rao, K. V. H. Sastry, H. C. Tripathi, J. Jagmohan, and J. K. Malik, “Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens,” British Poultry Science, vol. 46, no. 5, pp. 615–620, 2005.
- K. Naora, N. Ichikawa, H. Hirano, and K. Iwamoto, “Distribution of ciprofloxacin into the central nervous system in rats with acute renal or hepatic failure,” Journal of Pharmacy and Pharmacology, vol. 51, no. 5, pp. 609–616, 1999.
- J.-L. Riond, K. Tyczkowska, and J. E. Riviere, “Pharmacokinetics and metabolic inertness of doxycycline in calves with mature or immature rumen function,” American Journal of Veterinary Research, vol. 50, no. 8, pp. 1329–1333, 1989.
- H. Yu, H. Y. Wang, and Z. M. Sun, “The pharmacokinetics of ciprofloxacin in patients with renal function of various degrees,” Zhonghua Nei Ke Za Zhi, vol. 33, no. 7, pp. 449–451, 1994.
- A. Forrest, D. E. Nix, C. H. Ballow, T. F. Goss, M. C. Birmingham, and J. J. Schentag, “Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients,” Antimicrobial Agents and Chemotherapy, vol. 37, no. 5, pp. 1073–1081, 1993.
- K. J. Madaras-Kelly, B. E. Ostergaard, L. B. Hovde, and J. C. Rotschafer, “Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model,” Antimicrobial Agents and Chemotherapy, vol. 40, no. 3, pp. 627–632, 1996.
- H. Lode, K. Borner, and P. Koeppe, “Pharmacodynamics of fluoroquinolones,” Clinical Infectious Diseases, vol. 27, no. 1, pp. 33–39, 1998.
- M. N. Dudley, “Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones,” American Journal of Medicine, vol. 91, no. 6, supplement 1, pp. S45–S50, 1991.
- G. L. Drusano, D. E. Johnson, M. Rosen, and H. C. Standiford, “Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis,” Antimicrobial Agents and Chemotherapy, vol. 37, no. 3, pp. 483–490, 1993.
- R. D. Walker, “The use of fluoroquinolones for companion animal antimicrobial therapy,” Australian Veterinary Journal, vol. 78, no. 2, pp. 84–90, 2000.
- S. Chulavatnatol, B. Chindavijak, A. Vibhagool, W. Wanabukul, C. Sriapha, and C. Sirisangtragul, “Pharmacokinetics of levofloxacin in healthy Thai male volunteers,” Journal of the Medical Association of Thailand, vol. 82, no. 11, pp. 1127–1135, 1999.